These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38558423)

  • 21. Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.
    Kawaguchi H; Terai Y; Tanabe A; Sasaki H; Takai M; Fujiwara S; Ashihara K; Tanaka Y; Tanaka T; Tsunetoh S; Kanemura M; Ohmichi M
    J Ovarian Res; 2014 Apr; 7():38. PubMed ID: 24713296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. YYB-101, a Humanized Antihepatocyte Growth Factor Monoclonal Antibody, Inhibits Ovarian Cancer Cell Motility and Proliferation.
    Kim HJ; Heo K
    Anticancer Res; 2021 Feb; 41(2):671-678. PubMed ID: 33517271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models.
    Santiago-O'Farrill JM; Weroha SJ; Hou X; Oberg AL; Heinzen EP; Maurer MJ; Pang L; Rask P; Amaravadi RK; Becker SE; Romero I; Rubio MJ; Matias-Guiu X; Santacana M; Llombart-Cussac A; Poveda A; Lu Z; Bast RC
    Cancer; 2020 Feb; 126(4):894-907. PubMed ID: 31714594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.
    Gritsina G; Xiao F; O'Brien SW; Gabbasov R; Maglaty MA; Xu RH; Thapa RJ; Zhou Y; Nicolas E; Litwin S; Balachandran S; Sigal LJ; Huszar D; Connolly DC
    Mol Cancer Ther; 2015 Apr; 14(4):1035-47. PubMed ID: 25646015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prucalopride Inhibits Proliferation of Ovarian Cancer Cells via Phosphatidylinositol 3-Kinase (PI3K) Signaling Pathway.
    Liu X; Xu Y; Zhang L; Liu T; Zhang H
    Med Sci Monit; 2018 Jun; 24():4137-4145. PubMed ID: 29909423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.
    Gao Y; Shan N; Zhao C; Wang Y; Xu F; Li J; Yu X; Gao L; Yi Z
    Int J Clin Exp Pathol; 2015; 8(5):4923-32. PubMed ID: 26191185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chloroquine reverses chemoresistance via upregulation of p21
    Hwang JR; Kim WY; Cho YJ; Ryu JY; Choi JJ; Jeong SY; Kim MS; Kim JH; Paik ES; Lee YY; Han HD; Lee JW
    Cell Death Dis; 2020 Dec; 11(12):1034. PubMed ID: 33277461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bithionol inhibits ovarian cancer cell growth in vitro - studies on mechanism(s) of action.
    Ayyagari VN; Brard L
    BMC Cancer; 2014 Feb; 14():61. PubMed ID: 24495391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Icaritin induces ovarian cancer cell apoptosis through activation of p53 and inhibition of Akt/mTOR pathway.
    Gao L; Chen M; Ouyang Y; Li R; Zhang X; Gao X; Lin S; Wang X
    Life Sci; 2018 Jun; 202():188-194. PubMed ID: 29625193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer.
    Garrett LA; Growdon WB; Rueda BR; Foster R
    J Ovarian Res; 2016 Sep; 9(1):58. PubMed ID: 27633667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeic acid phenethyl ester inhibits the progression of ovarian cancer by regulating NF-?B signaling.
    Liu GL; Han NZ; Liu SS
    Biomed Pharmacother; 2018 Mar; 99():825-831. PubMed ID: 29710481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A strategy to combine pathway-targeted low toxicity drugs in ovarian cancer.
    Delaney JR; Patel C; McCabe KE; Lu D; Davis MA; Tancioni I; von Schalscha T; Bartakova A; Haft C; Schlaepfer DD; Stupack DG
    Oncotarget; 2015 Oct; 6(31):31104-18. PubMed ID: 26418751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NEO212 induces mitochondrial apoptosis and impairs autophagy flux in ovarian cancer.
    Song X; Liu L; Chang M; Geng X; Wang X; Wang W; Chen TC; Xie L; Song X
    J Exp Clin Cancer Res; 2019 Jun; 38(1):239. PubMed ID: 31174569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer.
    Wen Y; Graybill WS; Previs RA; Hu W; Ivan C; Mangala LS; Zand B; Nick AM; Jennings NB; Dalton HJ; Sehgal V; Ram P; Lee JS; Vivas-Mejia PE; Coleman RL; Sood AK
    Clin Cancer Res; 2015 Jan; 21(2):448-59. PubMed ID: 25416196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scutellarein induces apoptosis and inhibits proliferation, migration, and invasion in ovarian cancer via inhibition of EZH2/FOXO1 signaling.
    Lang X; Chen Z; Yang X; Yan Q; Xu M; Liu W; He Q; Zhang Y; Cheng W; Zhao W
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22870. PubMed ID: 34350670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells.
    Kim HJ; Hwang KE; Park DS; Oh SH; Jun HY; Yoon KH; Jeong ET; Kim HR; Kim YS
    J Transl Med; 2017 May; 15(1):123. PubMed ID: 28569199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paeonol induces cytoprotective autophagy via blocking the Akt/mTOR pathway in ovarian cancer cells.
    Gao L; Wang Z; Lu D; Huang J; Liu J; Hong L
    Cell Death Dis; 2019 Aug; 10(8):609. PubMed ID: 31406198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VDX-111 targets proliferative pathways in canine cancer cell lines.
    Farrell KB; Das S; Nordeen SK; Lambert JR; Thamm DH
    PLoS One; 2024; 19(5):e0303470. PubMed ID: 38771847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer.
    Konstantinopoulos PA; Wilson AJ; Saskowski J; Wass E; Khabele D
    Gynecol Oncol; 2014 Jun; 133(3):599-606. PubMed ID: 24631446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.